craft-sa-dev Home  

PMC:1584416 / 31591-32355 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T9280 0-8 NN denotes Genotype
T9282 8-9 HYPH denotes –
T9281 9-18 NN denotes Phenotype
T9283 19-32 NNS denotes Relationships
T9284 33-35 IN denotes in
T9285 36-39 NN denotes XPD
T9286 40-49 NNS denotes Disorders
T9287 49-162 sentence denotes According to the current monoallelic hypothesis, phenotype is determined solely by the causative allele product.
T9288 50-59 VBG denotes According
T9290 60-62 IN denotes to
T9291 63-66 DT denotes the
T9293 67-74 JJ denotes current
T9294 75-86 JJ denotes monoallelic
T9292 87-97 NN denotes hypothesis
T9295 97-99 , denotes ,
T9296 99-108 NN denotes phenotype
T9297 109-111 VBZ denotes is
T9289 112-122 VBN denotes determined
T9298 123-129 RB denotes solely
T9299 130-132 IN denotes by
T9300 133-136 DT denotes the
T9302 137-146 JJ denotes causative
T9303 147-153 NN denotes allele
T9301 154-161 NN denotes product
T9304 161-162 . denotes .
T9305 162-240 sentence denotes If a second, different allele is present, it is considered a functional null.
T9306 163-165 IN denotes If
T9308 166-167 DT denotes a
T9310 168-174 JJ denotes second
T9311 174-176 , denotes ,
T9312 176-185 JJ denotes different
T9309 186-192 NN denotes allele
T9307 193-195 VBZ denotes is
T9314 196-203 JJ denotes present
T9315 203-205 , denotes ,
T9316 205-207 PRP denotes it
T9317 208-210 VBZ denotes is
T9313 211-221 VBN denotes considered
T9318 222-223 DT denotes a
T9320 224-234 JJ denotes functional
T9319 235-239 NN denotes null
T9321 239-240 . denotes .
T9322 240-340 sentence denotes There is a lack of any correlation between the site of the XPD mutation and the resulting disorder.
T9323 241-246 EX denotes There
T9324 247-249 VBZ denotes is
T9325 250-251 DT denotes a
T9326 252-256 NN denotes lack
T9327 257-259 IN denotes of
T9328 260-263 DT denotes any
T9329 264-275 NN denotes correlation
T9330 276-283 IN denotes between
T9331 284-287 DT denotes the
T9332 288-292 NN denotes site
T9333 293-295 IN denotes of
T9334 296-299 DT denotes the
T9336 300-303 NN denotes XPD
T9335 304-312 NN denotes mutation
T9337 313-316 CC denotes and
T9338 317-320 DT denotes the
T9340 321-330 VBG denotes resulting
T9339 331-339 NN denotes disorder
T9341 339-340 . denotes .
T9342 340-456 sentence denotes We propose a biallelic hypothesis for compound heterozygotes in which both alleles can contribute to the phenotype.
T9343 341-343 PRP denotes We
T9344 344-351 VBP denotes propose
T9345 352-353 DT denotes a
T9347 354-363 JJ denotes biallelic
T9346 364-374 NN denotes hypothesis
T9348 375-378 IN denotes for
T9349 379-387 NN denotes compound
T9350 388-401 NNS denotes heterozygotes
T9351 402-404 IN denotes in
T9353 405-410 WDT denotes which
T9354 411-415 DT denotes both
T9355 416-423 NNS denotes alleles
T9356 424-427 MD denotes can
T9352 428-438 VB denotes contribute
T9357 439-441 IN denotes to
T9358 442-445 DT denotes the
T9359 446-455 NN denotes phenotype
T9360 455-456 . denotes .
T9361 456-693 sentence denotes Examples of compound heterozygous patients in which a second, presumed null allele is likely to contribute to disease outcome are provided above in comparison to corresponding homo- or hemizygous patients with the same causative allele.
T9362 457-465 NNS denotes Examples
T9364 466-468 IN denotes of
T9365 469-477 NN denotes compound
T9367 478-490 JJ denotes heterozygous
T9366 491-499 NNS denotes patients
T9368 500-502 IN denotes in
T9370 503-508 WDT denotes which
T9371 509-510 DT denotes a
T9373 511-517 JJ denotes second
T9374 517-519 , denotes ,
T9375 519-527 JJ denotes presumed
T9376 528-532 JJ denotes null
T9372 533-539 NN denotes allele
T9369 540-542 VBZ denotes is
T9377 543-549 JJ denotes likely
T9378 550-552 TO denotes to
T9379 553-563 VB denotes contribute
T9380 564-566 IN denotes to
T9381 567-574 NN denotes disease
T9382 575-582 NN denotes outcome
T9383 583-586 VBP denotes are
T9363 587-595 VBN denotes provided
T9384 596-601 RB denotes above
T9385 602-604 IN denotes in
T9386 605-615 NN denotes comparison
T9387 616-618 IN denotes to
T9388 619-632 VBG denotes corresponding
T9390 633-637 AFX denotes homo
T9392 637-638 HYPH denotes -
T9393 639-641 CC denotes or
T9391 642-652 JJ denotes hemizygous
T9389 653-661 NNS denotes patients
T9394 662-666 IN denotes with
T9395 667-670 DT denotes the
T9397 671-675 JJ denotes same
T9398 676-685 JJ denotes causative
T9396 686-692 NN denotes allele
T9399 692-693 . denotes .
T9400 693-764 sentence denotes Numbers in the schematic of the protein indicate the helicase domains.
T9401 694-701 NNS denotes Numbers
T9403 702-704 IN denotes in
T9404 705-708 DT denotes the
T9405 709-718 NN denotes schematic
T9406 719-721 IN denotes of
T9407 722-725 DT denotes the
T9408 726-733 NN denotes protein
T9402 734-742 VBP denotes indicate
T9409 743-746 DT denotes the
T9411 747-755 NN denotes helicase
T9410 756-763 NNS denotes domains
T9412 763-764 . denotes .
R6329 T9280 T9281 compound Genotype,Phenotype
R6330 T9281 T9283 compound Phenotype,Relationships
R6331 T9282 T9281 punct –,Phenotype
R6332 T9284 T9283 prep in,Relationships
R6333 T9285 T9286 compound XPD,Disorders
R6334 T9286 T9284 pobj Disorders,in
R6335 T9288 T9289 prep According,determined
R6336 T9290 T9288 prep to,According
R6337 T9291 T9292 det the,hypothesis
R6338 T9292 T9290 pobj hypothesis,to
R6339 T9293 T9292 amod current,hypothesis
R6340 T9294 T9292 amod monoallelic,hypothesis
R6341 T9295 T9289 punct ", ",determined
R6342 T9296 T9289 nsubjpass phenotype,determined
R6343 T9297 T9289 auxpass is,determined
R6344 T9298 T9299 advmod solely,by
R6345 T9299 T9289 agent by,determined
R6346 T9300 T9301 det the,product
R6347 T9301 T9299 pobj product,by
R6348 T9302 T9301 amod causative,product
R6349 T9303 T9301 compound allele,product
R6350 T9304 T9289 punct .,determined
R6351 T9306 T9307 mark If,is
R6352 T9307 T9313 advcl is,considered
R6353 T9308 T9309 det a,allele
R6354 T9309 T9307 nsubj allele,is
R6355 T9310 T9309 amod second,allele
R6356 T9311 T9309 punct ", ",allele
R6357 T9312 T9309 amod different,allele
R6358 T9314 T9307 acomp present,is
R6359 T9315 T9313 punct ", ",considered
R6360 T9316 T9313 nsubjpass it,considered
R6361 T9317 T9313 auxpass is,considered
R6362 T9318 T9319 det a,null
R6363 T9319 T9313 oprd null,considered
R6364 T9320 T9319 amod functional,null
R6365 T9321 T9313 punct .,considered
R6366 T9323 T9324 expl There,is
R6367 T9325 T9326 det a,lack
R6368 T9326 T9324 attr lack,is
R6369 T9327 T9326 prep of,lack
R6370 T9328 T9329 det any,correlation
R6371 T9329 T9327 pobj correlation,of
R6372 T9330 T9329 prep between,correlation
R6373 T9331 T9332 det the,site
R6374 T9332 T9330 pobj site,between
R6375 T9333 T9332 prep of,site
R6376 T9334 T9335 det the,mutation
R6377 T9335 T9333 pobj mutation,of
R6378 T9336 T9335 compound XPD,mutation
R6379 T9337 T9332 cc and,site
R6380 T9338 T9339 det the,disorder
R6381 T9339 T9332 conj disorder,site
R6382 T9340 T9339 amod resulting,disorder
R6383 T9341 T9324 punct .,is
R6384 T9343 T9344 nsubj We,propose
R6385 T9345 T9346 det a,hypothesis
R6386 T9346 T9344 dobj hypothesis,propose
R6387 T9347 T9346 amod biallelic,hypothesis
R6388 T9348 T9346 prep for,hypothesis
R6389 T9349 T9350 compound compound,heterozygotes
R6390 T9350 T9348 pobj heterozygotes,for
R6391 T9351 T9352 prep in,contribute
R6392 T9352 T9346 relcl contribute,hypothesis
R6393 T9353 T9351 pobj which,in
R6394 T9354 T9355 det both,alleles
R6395 T9355 T9352 nsubj alleles,contribute
R6396 T9356 T9352 aux can,contribute
R6397 T9357 T9352 prep to,contribute
R6398 T9358 T9359 det the,phenotype
R6399 T9359 T9357 pobj phenotype,to
R6400 T9360 T9344 punct .,propose
R6401 T9362 T9363 nsubjpass Examples,provided
R6402 T9364 T9362 prep of,Examples
R6403 T9365 T9366 nmod compound,patients
R6404 T9366 T9364 pobj patients,of
R6405 T9367 T9366 amod heterozygous,patients
R6406 T9368 T9369 prep in,is
R6407 T9369 T9366 relcl is,patients
R6408 T9370 T9368 pobj which,in
R6409 T9371 T9372 det a,allele
R6410 T9372 T9369 nsubj allele,is
R6411 T9373 T9372 amod second,allele
R6412 T9374 T9372 punct ", ",allele
R6413 T9375 T9376 amod presumed,null
R6414 T9376 T9372 amod null,allele
R6415 T9377 T9369 acomp likely,is
R6416 T9378 T9379 aux to,contribute
R6417 T9379 T9377 xcomp contribute,likely
R6418 T9380 T9379 prep to,contribute
R6419 T9381 T9382 compound disease,outcome
R6420 T9382 T9380 pobj outcome,to
R6421 T9383 T9363 auxpass are,provided
R6422 T9384 T9363 advmod above,provided
R6423 T9385 T9363 prep in,provided
R6424 T9386 T9385 pobj comparison,in
R6425 T9387 T9386 prep to,comparison
R6426 T9388 T9389 amod corresponding,patients
R6427 T9389 T9387 pobj patients,to
R6428 T9390 T9391 advmod homo,hemizygous
R6429 T9391 T9389 amod hemizygous,patients
R6430 T9392 T9391 punct -,hemizygous
R6431 T9393 T9391 cc or,hemizygous
R6432 T9394 T9389 prep with,patients
R6433 T9395 T9396 det the,allele
R6434 T9396 T9394 pobj allele,with
R6435 T9397 T9396 amod same,allele
R6436 T9398 T9396 amod causative,allele
R6437 T9399 T9363 punct .,provided
R6438 T9401 T9402 nsubj Numbers,indicate
R6439 T9403 T9401 prep in,Numbers
R6440 T9404 T9405 det the,schematic
R6441 T9405 T9403 pobj schematic,in
R6442 T9406 T9405 prep of,schematic
R6443 T9407 T9408 det the,protein
R6444 T9408 T9406 pobj protein,of
R6445 T9409 T9410 det the,domains
R6446 T9410 T9402 dobj domains,indicate
R6447 T9411 T9410 compound helicase,domains
R6448 T9412 T9402 punct .,indicate